Table 2.
HC | TB | DM | TB+DM | TB VS DM | TB VS TB+DM | DM VS TB+DM | |
---|---|---|---|---|---|---|---|
n = 133 | n = 113 | n = 59 | n = 74 | P value | P value | P value | |
PLT, 109/L | 219.455.4 | 218.456.9 | 207.040.3 | 208.750.1 | 0.3050 | 0.1936 | 0.8575 |
MPV, fL | 9.601.21 | 9.421.01 | 10.921.17 | 9.951.25 | <0.0001* | 0.0041* | <0.0001* |
PDW, % | 16.10.8 | 15.90.6 | 15.91.3 | 16.00.8 | 0.6804 | 0.3821 | 0.3409 |
PCT, % | 0.210.05 | 0.200.05 | 0.220.04 | 0.200.05 | 0.0397* | 0.7066 | 0.0121* |
Platelet associated parameters and statistic results among the four groups. HC Healthy community controls, TB Tuberculosis group, DM Diabetes group, TB+DM TB-DM co-morbidity group, PLT Platelet, MPV Mean platelet volume, PDW Platelet distribution width, PCT Plateletcrit. *Significant value (P < 0.05)